Baillie Gifford & Co’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-25,583
Closed -$78K 213
2013
Q3
$78K Hold
25,583
﹤0.01% 206
2013
Q2
$82K Buy
+25,583
New +$82K ﹤0.01% 179